With multi-drug resistant bacteria and promotion of antimicrobial stewardship, the treatment of pneumonia can be a challenge. This Capsule discusses the recent Infectious Diseases Society of America (IDSA) guideline update, HAP risk-factors, and selecting appropriate antibiotics.